Mona A. Mahran

823 total citations
26 papers, 690 citations indexed

About

Mona A. Mahran is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mona A. Mahran has authored 26 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Mona A. Mahran's work include Synthesis and biological activity (16 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Tuberculosis Research and Epidemiology (4 papers). Mona A. Mahran is often cited by papers focused on Synthesis and biological activity (16 papers), Bioactive Compounds and Antitumor Agents (4 papers) and Tuberculosis Research and Epidemiology (4 papers). Mona A. Mahran collaborates with scholars based in Egypt, Saudi Arabia and United States. Mona A. Mahran's co-authors include Hussein I. El‐Subbagh, Farid A. Badria, Abdulrahman M. Al‐Obaid, Ramnarayan S. Randad, Ahmed S. Mehanna, Samia William, Mostafa M. M. El-Miligy, A. A. B. HAZZAA, Ibrahim M. Labouta and Ola H. Rizk and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and Organic & Biomolecular Chemistry.

In The Last Decade

Mona A. Mahran

24 papers receiving 671 citations

Peers

Mona A. Mahran
Paul Hebeisen Switzerland
Peng‐Cheng Lv China
Gregory A. Rener United States
Mohammed A. Khedr Egypt
Hanumappa Ananda India
Amin Mirza United Kingdom
Michal Uher Slovakia
Darpan Kaushik India
Shelly Pathania India
Adileh Ayati Iran
Paul Hebeisen Switzerland
Mona A. Mahran
Citations per year, relative to Mona A. Mahran Mona A. Mahran (= 1×) peers Paul Hebeisen

Countries citing papers authored by Mona A. Mahran

Since Specialization
Citations

This map shows the geographic impact of Mona A. Mahran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona A. Mahran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona A. Mahran more than expected).

Fields of papers citing papers by Mona A. Mahran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona A. Mahran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona A. Mahran. The network helps show where Mona A. Mahran may publish in the future.

Co-authorship network of co-authors of Mona A. Mahran

This figure shows the co-authorship network connecting the top 25 collaborators of Mona A. Mahran. A scholar is included among the top collaborators of Mona A. Mahran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona A. Mahran. Mona A. Mahran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Teleb, Mohamed, et al.. (2024). The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapy. Bioorganic Chemistry. 145. 107179–107179. 5 indexed citations
4.
El-Miligy, Mostafa M. M., et al.. (2024). Imparting aromaticity to 2-pyridone derivatives by O -alkylation resulted in new competitive and non-competitive PIM-1 kinase inhibitors with caspase-activated apoptosis. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2304044–2304044. 5 indexed citations
5.
Mahran, Mona A., et al.. (2022). New tetrahydropyrimidine-1,2,3-triazole clubbed compounds: Antitubercular activity and Thymidine Monophosphate Kinase (TMPKmt) inhibition. Bioorganic Chemistry. 131. 106312–106312. 15 indexed citations
6.
Akaji, Kenichi, Ross P. McGeary, Waleed M. Hussein, et al.. (2020). Design, synthesis, biological evaluation and in silico studies of certain aryl sulfonyl hydrazones conjugated with 1,3-diaryl pyrazoles as potent metallo-β-lactamase inhibitors. Bioorganic Chemistry. 105. 104386–104386. 26 indexed citations
7.
Mahran, Mona A., Mohamed Teleb, & Elwy H. Abdelkader. (2019). 100 years of sickle cell disease research: etiology, pathophysiology and rational drug design (part 1). Beni-Suef University Journal of Basic and Applied Sciences. 8(1).
8.
Rizk, Ola H., et al.. (2018). Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents. Bioorganic Chemistry. 80. 721–732. 13 indexed citations
9.
El-Miligy, Mostafa M. M., et al.. (2018). Design, synthesis and docking study of pyridine and thieno[2,3-b] pyridine derivatives as anticancer PIM-1 kinase inhibitors. Bioorganic Chemistry. 80. 674–692. 61 indexed citations
10.
Omar, Abdelsattar M., Mona A. Mahran, Mohini S. Ghatge, et al.. (2016). Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin. Molecules. 21(8). 1057–1057. 5 indexed citations
11.
Omar, Abdelsattar M., Mona A. Mahran, Mohini S. Ghatge, et al.. (2015). Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents. Organic & Biomolecular Chemistry. 13(22). 6353–6370. 17 indexed citations
12.
Mahran, Mona A., et al.. (2012). Synthesis and biological evaluation of novel benzoquinones as potential antimicrobial agents. Medicinal Chemistry Research. 22(2). 841–851. 3 indexed citations
13.
Mahran, Mona A., et al.. (2012). Synthesis and biological evaluation of novel hydroquinone dimethyl ethers as potential anticancer and antimicrobial agents. Medicinal Chemistry Research. 22(8). 3760–3778. 6 indexed citations
14.
Mahran, Mona A., et al.. (2007). Design, synthesis, and in vitro evaluation of cytotoxic activity of new substituted 1,4-benzoquinones and hydroquinones. Medicinal Chemistry Research. 16(2). 49–77. 12 indexed citations
15.
Rizk, Ola H., et al.. (2005). Synthesis of Some New Antimicrobial Thiadiazolyl and Oxadiazolyl Quinoline Derivatives. Medicinal Chemistry Research. 14(5). 260–273. 7 indexed citations
16.
Habib, Nargues S. & Mona A. Mahran. (2004). Synthesis and biological evaluation of novel naphthoquinone derivatives as potential anticancer and antimicrobial agents.. PubMed. 143(8). 299–307. 3 indexed citations
17.
Mahran, Mona A., et al.. (2003). Synthesis of Some New Benzothiazole Derivatives as Potential Antimicrobial and Antiparasitic Agents.. ChemInform. 34(46). 527–30. 16 indexed citations
18.
Mahran, Mona A.. (2000). Quantitative structure-activity relationship of phenoxy and benzyloxy acid derivatives as antisickling agents.. PubMed. 139(2). 73–80. 1 indexed citations
19.
El‐Subbagh, Hussein I., et al.. (1998). Synthesis and biological evaluation of new cyclopenteno[b]thiophene derivatives as local anesthetic and antiarrhythmic agents.. PubMed. 53(1). 24–8. 3 indexed citations
20.
Randad, Ramnarayan S., et al.. (1991). Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. Journal of Medicinal Chemistry. 34(2). 752–757. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Hebeisen Breakdown of academic impact, for papers by Peng‐Cheng Lv Breakdown of academic impact, for papers by Gregory A. Rener Breakdown of academic impact, for papers by Mohammed A. Khedr Breakdown of academic impact, for papers by Hanumappa Ananda Breakdown of academic impact, for papers by Amin Mirza Breakdown of academic impact, for papers by Michal Uher Breakdown of academic impact, for papers by Darpan Kaushik Breakdown of academic impact, for papers by Shelly Pathania Breakdown of academic impact, for papers by Adileh Ayati
Rankless by CCL
2026